Advances and Perspectives in the Treatment of T-PLL

PURPOSE OF REVIEW: T cell prolymphocytic leukemia (T-PLL) is a rare mature T cell tumor. Available treatment options in this aggressive disease are largely inefficient and patient outcomes are highly dissatisfactory. Current therapeutic strategies mainly employ the CD52-antibody alemtuzumab as the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Till, von Jan, Jana, Wahnschaffe, Linus, Herling, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230055/
https://www.ncbi.nlm.nih.gov/pubmed/32034661
http://dx.doi.org/10.1007/s11899-020-00566-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230055/
https://www.ncbi.nlm.nih.gov/pubmed/32034661
http://dx.doi.org/10.1007/s11899-020-00566-5

Ejemplares similares